SCHEMBL13045211

SCHEMBL13045211

CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Cc4ccccc4)cc3)c2c1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3685569 0.90 MAP2K1 (0.81) MAP2K1
SCHEMBL13046479 0.89 MAP2K1 (1.00) MAP2K1
SCHEMBL3692710 0.89 MAP2K1 (1.00) MAP2K1
SCHEMBL5138612 0.87 MAP2K1 (0.82) MAP2K1
SCHEMBL13045284 0.85 MAP2K1 (0.83) MAP2K1
SCHEMBL3688790 0.84 MAP2K1 (0.87) MAP2K1
SCHEMBL3690055 0.84 MAP2K1 (0.83) MAP2K1
SCHEMBL3693408 0.84 MAP2K1 (1.00) MAP2K1
SCHEMBL3693846 0.83 MAP2K1 (0.82) MAP2K1
SCHEMBL3693390 0.83 MAP2K1 (0.85) MAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578351-B1 PYRROLOPYRIDAZINE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PROLIFERATIVE DISORDERS BRISTOL MYERS SQUIBB CO (US) 2010-12-08 EP disclosed